白癜风治疗影响评分(VITs):基于ComPaRe白癜风电子队列的治疗负担问卷开发与验证
研究在法国ComPaRe白癜风电子队列中开发并验证患者报告的白癜风治疗负担测量工具VITs。基于文献回顾和204例患者开放式调查定性分析生成条目,343例成人参与者完成验证。VITs为19条目问卷,含四个域,总分与DLQI、VIPs和TBQ良好相关,重测信度ICC 0.705(95% CI 0.491-0.818)。
要点
- VITs为19条目患者报告问卷,评估白癜风治疗负担,含四个域。
- VITs总分与DLQI、VIPs和TBQ评分良好相关,重测信度ICC 0.705。
- 该工具可用于临床识别治疗负担高的白癜风患者。
核心结论
- 开发了具有良好心理测量学特性的白癜风治疗负担患者报告测量工具VITs。
研究设计与样本
- 研究嵌套于法国ComPaRe白癜风在线电子队列。
- 条目来源于文献回顾和对204例白癜风患者开放式调查的定性分析。
- 343例成人参与者参与VITs验证。
- 通过比较VITs评分与DLQI、VIPs和TBQ评分评估结构效度。
- 通过间隔15±10天的重测评估信度。
主要发现
- VITs为19条目问卷,结果提示四个域:「寻找医生」、「光疗」、「局部治疗」和「对户外活动及光防护的影响」。
- VITs总分与DLQI、VIP和TBQ评分良好相关。
- 重测一致性良好(ICC 0.705,95% CI 0.491-0.818)。
关键数值与推荐
- VITs含19个条目,评估四个域:寻找医生、光疗、局部治疗、对户外活动及光防护的影响。
- 重测信度ICC为0.705(95% CI 0.491-0.818)。
临床怎么用
- VITs可作为患者报告工具用于评估白癜风患者的治疗负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitiligo management is challenging and requires long-term adherence of patients who often complain of the burden associated with treatment. OBJECTIVE: To develop and validate a patient reported measurement of the burden of treatment in vitiligo. METHODS: The study was nested within the ComPaRe Vitiligo e-cohort, an online e-cohort of vitiligo patients in France. Items were derived from a literature review and from the qualitative analysis of a survey using open-ended questions of 204 patients with Vitiligo. Construct validity of the resulting instrument was assessed by comparing the instrument's score to the Dermatology Life Quality Index (DLQI), Vitiligo Impact Patient score (VIPs) and Treatment Burden Questionnaire (TBQ) scores. Reliability was assessed by test-retest with 15 ± 10 days of interval between both assessments. RESULTS: In total, 343 adult participants participated in the validation of the Vitiligo Treatment Impact score (VITs). The VITs is a 19-item questionnaire assessing the burden of treatment in patients with vitiligo with results suggesting four domains ('Finding a doctor', 'Phototherapy', 'Topical treatment' and 'Impact on outdoor activities and photoprotection'). The VITs total score was well correlated with the DLQI, VIP and TBQ scores. Agreement between test and retest was good (ICC 0.705, 95% CI 0.491-0.818). CONCLUSIONS: We developed a patient reported measurement of the burden of treatment in vitiligo with good psychometric properties.
引用
- Shourick J, Seneschal J, Andreu N, et al. Vitiligo Treatment Impact score (VITs): development and validation of a vitiligo burden of treatment questionnaire using the ComPaRe Vitiligo e-cohort. J Eur Acad Dermatol Venereol. 2021. PMID: 34657353. doi:10.1111/jdv.17742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。